These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20478069)

  • 1. Labelled drug-related public expenditure in relation to gross domestic product (GDP) in Europe: a luxury good?
    Prieto L
    Subst Abuse Treat Prev Policy; 2010 May; 5():9. PubMed ID: 20478069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International health care spending.
    Schieber GJ; Puollier JP
    Health Aff (Millwood); 1986; 5(3):111-22. PubMed ID: 3098657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public spending for illegal drug and alcohol treatment in hospitals: an EU cross-country comparison.
    Lievens D; Vander Laenen F; Christiaens J
    Subst Abuse Treat Prev Policy; 2014 Jun; 9():26. PubMed ID: 24981850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hong Kong domestic health spending: financial years 1989/90 to 2008/09.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2012 Aug; 18(4 Suppl 4):1-23. PubMed ID: 22947491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Health care expenditure in Spain compared with developed Europe, 1985-2001. The Spanish primary health care, the European Cinderella].
    Simó Miñana J; Gérvas Camacho J; Seguí Díaz M; Pablo González Rd; Domínguez Velázquez J
    Aten Primaria; 2004 Nov; 34(9):472-81. PubMed ID: 15563785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.
    Leung GM; Tin KY; Yeung GM; Leung ES; Tsui EL; Lam DW; Tsang CS; Fung AY; Lo SV
    Hong Kong Med J; 2008 Apr; 14 Suppl 2():2-23. PubMed ID: 18587162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hong Kong domestic health spending: financial years 1989/90 to 2010/11.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Yeung AY; Chui AW; Tay MS
    Hong Kong Med J; 2013 Dec; 19(6 Suppl 7):1-24. PubMed ID: 24356244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Do we spend too much on medications? Pharmaceutical expenditures, an absolutely essential item in European countries].
    Simó Miñan J; de Pablo González R; Ramos Maestre MJ; Gaztambide Ganuza MS
    Aten Primaria; 2004 Mar; 33(5):244-53. PubMed ID: 15033093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hong Kong domestic health spending: financial years 1989/90 to 2009/10.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2013 Apr; 19(2 Suppl 3):1-24. PubMed ID: 23589588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hong Kong domestic health spending: financial years 1989/90 to 2011/12.
    Tin KY; Tsoi PK; Lee YH; Chong DS; Lam DW; Yeung AY; Ma ES; Maw CK
    Hong Kong Med J; 2015 Jun; 21(3 Suppl 3):1-24. PubMed ID: 26045183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National health expenditures: a global analysis.
    Murray CJ; Govindaraj R; Musgrove P
    Bull World Health Organ; 1994; 72(4):623-37. PubMed ID: 7923542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical expenditure and gross domestic product: Evidence of simultaneous effects using a two-step instrumental variables strategy.
    Shaikh M; Gandjour A
    Health Econ; 2019 Jan; 28(1):101-122. PubMed ID: 30306669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UK and Twenty Comparable Countries GDP-Expenditure-on-Health 1980-2013: The Historic and Continued Low Priority of UK Health-Related Expenditure.
    Harding AJ; Pritchard C
    Int J Health Policy Manag; 2016 Sep; 5(9):519-523. PubMed ID: 27694678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Health care financing: is it enough and appropriate?].
    Puig-Junoy J
    Gac Sanit; 2006 Mar; 20 Suppl 1():96-102. PubMed ID: 16539971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public financing of health in developing countries: a cross-national systematic analysis.
    Lu C; Schneider MT; Gubbins P; Leach-Kemon K; Jamison D; Murray CJ
    Lancet; 2010 Apr; 375(9723):1375-87. PubMed ID: 20381856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The European challenges of funding orphan medicinal products.
    Szegedi M; Zelei T; Arickx F; Bucsics A; Cohn-Zanchetta E; Fürst J; Kamusheva M; Kawalec P; Petrova G; Slaby J; Stawowczyk E; Vocelka M; Zechmeister-Koss I; Kaló Z; Molnár MJ
    Orphanet J Rare Dis; 2018 Nov; 13(1):184. PubMed ID: 30396361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health Care Expenditure and GDP in Oil Exporting Countries: Evidence From OPEC Data, 1995-2012.
    Fazaeli AA; Ghaderi H; Salehi M; Fazaeli AR
    Glob J Health Sci; 2015 Jun; 8(2):93-8. PubMed ID: 26383195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underlying Differences in Health Spending Within the World Health Organisation Europe Region-Comparing EU15, EU Post-2004, CIS, EU Candidate, and CARINFONET Countries.
    Jakovljevic M; Fernandes PO; Teixeira JP; Rancic N; Timofeyev Y; Reshetnikov V
    Int J Environ Res Public Health; 2019 Aug; 16(17):. PubMed ID: 31443381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of health financing patterns and the way forward in the WHO African Region.
    Kirigia JM; Preker A; Carrin G; Mwikisa C; Diarra-Nama AJ
    East Afr Med J; 2006 Sep; 83(9 Suppl):S1-28. PubMed ID: 17476860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.